Skip to main content
Clinical Trials/NCT00852865
NCT00852865CompletedPhase 1

Effect of a Dialy Consumption of a Probiotic (Lactobacillus Farciminis) on Hyperalgesia in Response to Thermal Stimulation

Lallemand SAS1 site in 1 country48 target enrollmentStarted: February 2009Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
48
Locations
1
Primary Endpoint
Measurement of the mchanical pain threshold in primary and secondary areas by using a punctate stimulus.

Study Overview

Brief Summary

We want to analyse a possible effect of o dialy consumption of Lactobacillus farciminis on a hyperalgesia on response to thermal stimulation. A comparaison of results before and after three weeks of treatment will be made.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • healthy volunteers

Exclusion Criteria

  • consumption of yogurts

Arms & Interventions

1

Experimental

24 healthy volunteers consuming L.farciminis during three weeks

Intervention: Lactobacillus farciminis (Drug)

2

Placebo Comparator

24 healthy volunteers consuming placebo during three weeks

Intervention: Placebo (Drug)

Outcomes

Primary Outcomes

Measurement of the mchanical pain threshold in primary and secondary areas by using a punctate stimulus.

Secondary Outcomes

  • Measurement of cutaneous temperature of hyperalgesia areas

Investigators

Sponsor
Lallemand SAS
Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials

Lactobacillus Farciminis and Hyperalgesia | Clinical Trial